Page 48 - 79_03

J.
C.
Rodríguez
Rey

74. Dong,
B.,
Saha,
P.K.,
Huang,
W.,
Chen,
W.,
Abu-­-Elheiga,
L.A.,
Wakil,
S.J.,
Stevens,
R.D.,

Ilkayeva,
O.,
Newgard,
C.B.,
Chan,
L.,
et
al.
2009.
Activation
of
nuclear
receptor
CAR

ameliorates
diabetes
and
fatty
liver
disease.
Proc
Natl
Acad
Sci
U
S
A
106:18831-­-18836.

75. Lee,
J.M.,
Lee,
Y.K.,
Mamrosh,
J.L.,
Busby,
S.A.,
Griffin,
P.R.,
Pathak,
M.C.,
Ortlund,
E.A.,
and

Moore,
D.D.
2011.
A
nuclear-­-receptor-­-dependent
phosphatidylcholine
pathway
with

antidiabetic
effects.
Nature
474:506-­-510.

76. Anstee,
Q.M.,
and
Day,
C.P.
2012.
A
lipid
to
treat
non-­-alcoholic
fatty
liver
disease
-­-
the

dawn
of
'lipo-­-rehabilitation'?
J
Hepatol
56:987-­-989.

433